Joined the BIE Board as a Non-Executive Director in 2025.

Iain holds a PhD from the University of Sydney and an MBA from the University of Cambridge. He has worked in technology commercialisation since 2001, co-founded Apollo Therapeutics and CeresAgritech and is currently Board Chair at Agaricus Robotics Ltd. alongside working on an exciting new endeavour at the Medicines Discovery Catapult. 

Iain was Head of Life Sciences at Cambridge Enterprise for 18 years where he and his team helped create start-ups, including XO1, Mission Therapeutics, Gyroscope Therapeutics, Cambridge Epigenetix (now BiModal) and NoBACZ) and licence technology in fields as varied as psychiatric assessment, human therapeutics, biomarkers, veterinary products, lab tools and agritech. During this time Iain was also a Director and the Chair of Knowledge Exchange UK (formerly PraxisAuril Ltd), a not-for-profit company that trains practitioners in knowledge exchange in the UK, driving the organisation to a strong financial footing. 

Beyond his professional work, Iain was a co-chair of governors at Milton Road Primary School through the covid-19 pandemic and oversaw substantial school improvement.